KLBF:IDX
Kalbe Farma Tbk PT
IDR 785.00
arrow_upward
+1.29%(+10.00) 1D
10월 9일, 오후 4시 14분 38초 GMT+7 · IDR
search
모든 종목 코드
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoKLBF의 주요 통계 생성 중...
시가
IDR 780
고가
IDR 795
저가
IDR 770
시가총액
36.75조
평균 거래량
6583.11만
거래량
5655.88만
배당금
2.55%
분기 배당금
IDR 5
배당락일
2026. 6. 4.
주가수익률
9.87
52주 최고가
IDR 1,345
52주 최저가
IDR 630
EPS
IDR 80
유통 주식수
468.13억
직원 수
1만
시가
IDR 780
고가
IDR 795
저가
IDR 770
시가총액
36.75조
평균 거래량
6583.11만
거래량
5655.88만
배당금
2.55%
분기 배당금
IDR 5
배당락일
2026. 6. 4.
주가수익률
9.87
52주 최고가
IDR 1,345
52주 최저가
IDR 630
EPS
IDR 80
유통 주식수
468.13억
직원 수
1만
뉴스 기사
웹 소스 및 뉴스 파트너 제공
AD HOC NEWS
·
5시간 전
Kalbe Farma stock is unchanged at EUR 0.04 in weekend trading
AD HOC NEWS
·
2일 전
Kalbe Farma stock gains 1.32 percent in Jakarta
AD HOC NEWS
·
2일 전
Kiwoom gives Kalbe Farma stock a Hold rating
프로필
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Kalbe Farma Tbk PT에 관한 정보